![Petros Grivas: Our phase 2 trial of SG+Pembro in platinum-resistant IO-naive 2L setting](https://oncodaily.com/pub/uploads/2024/01/Petros-Grivas-e1724611822592.png)
Photo from Petros Grivas/X
Jan 29, 2024, 10:40
Petros Grivas: Our phase 2 trial of SG+Pembro in platinum-resistant IO-naive 2L setting
Petros Grivas, Clinical Director of Genitourinary Cancers Program, UW Medicine, shared on X/Twitter:
“Excited for our phase 2 trial of SG+Pembro in platinum-resistant IO-naive 2L setting published Journal of Clinical Oncology ORR 41%, CR 20%, mDOR 11mo (primary endpoint met!) supporting ECOG-ACRIN Cancer Research Group 8231 phase 3 trial launching soon!”
Visit the article website.
Source: Petros Grivas/X